How we do it
Nuvera brings a holistic approach to shaping industry-leading treatment experiences and patient support programs.
Our Approach.
When it comes to Patient Support, there is no one-solution or one-size-fits-all. A number of factors from patient needs and therapeutic area to brand’s clinical attributes and market conditions determine the right Treatment Experience.
We start with the specialty product and help our clients weave together patient needs, product attributes, and stakeholder environments into a seamless treatment experience:
-
Uncover & Crystalize Patient and HCP Needs
Through our unique frameworks, we develop a clear understanding of patient/HCP needs to enable the effective design of seamless support services.
-
Design Impactful Patient/HCP Support Experiences
We prioritize key moments along the patient journey and design meaningful interactions and services that reduce patient and HCP barriers to therapy.
-
Build Programs and Capabilities that are Patient-Centered
We plan and support the build outstanding delivery capabilities, including people, process and technology, to create the best experience for customers.
-
Optimize Patient and HCP Experience Strategy and Capabilities
We refine and continuously improve the Program while providing ongoing patient insights to your organization.
-
Read moreOvercoming the Challenges in Bringing Cell & Gene Therapies to Market – Part 4
As cell and gene therapies (CGTs) continue to enter the market, treatment centers have become the primary gatekeepers...
-
Read moreFree Drug and Access Equation: What Regeneron’s Otarmeni Decision Reveals About Specialty Product Access
Free drug removes price barriers, but Otarmeni shows why specialty therapy access still depends on PSPs, payers, and logistics.
-
Read moreOvercoming the Challenges in Bringing Cell & Gene Therapies to Market – Part 3
How CGT manufacturers can reduce financial risk and reimbursement burden for treatment centers adopting commercial therapies.
-
Read moreOvercoming the Challenges in Bringing Cell & Gene Therapies to Market – Part 2
How CGT manufacturers can reduce treatment center burden through better workflows, training, logistics, and system integration.
Get in touch.
We create effective treatment experience strategies through experience and market insights.
